Liver Transplantation

Article	Citations
Issue Information ‐ Instructions to Authors	93
Issue Information ‐ Author Checklist	53
Gastrointestinal Infection and Liver Injury Are the Risk Factors for Coronavirus Disease 2019 Inpatients With Assisted Ventilation	53
Deceased donor selection and management	45
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	44
Three Problems, Two Viruses, and One Man with a Vision and Voice: Larry Kramer, Medical Activist	43
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	42
Issue Information	41
Introducing the Certificate of Added Qualification (CAQ) Corner	39
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	39
Issue Information ‐ Instructions to Authors	38
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	37
Issue Information	37
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	35
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	35
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic	35
Reply	34
Incidence and risk factors for chronic rejection in pediatric liver transplantation	32
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	32
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	32
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	31
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	31
Semaglutide is effective in achieving weight loss in liver transplant recipients	30
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	30
Acute liver failure: Do we have a consensus regarding management?	30

Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	30
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	29
Making the best use of testing for blood phosphatidylethanol	28
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	28
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	27
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A non-invasive approach	25
Issue Information	25
Issue Information ‐ Author Checklist	25
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	25
Issue Information	25
Those Donor Leucocytes Again? This Time It’s VITT!	24
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: Creating a Multidisciplinary Team Greater Than the Sum of Its Parts?	24
Erratum	24
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	24
Operational tolerance is not always permanent	24
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	23
PRO: All patients should receive a palliative care consult during LT evaluation	23
Issue Information ‐ Author Checklist	23
Remembrance of a Passing Pandemic	23
PRO: Is the management of ACLF better in a liver-dedicated ICU?	23
Leveraging a Machine‐Learning Approach to Predict Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A Step in the Right Direction?	22
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	22
Demarcating the Exact Midplane of the Liver Using Indocyanine Green Near‐Infrared Fluorescence Imaging During Laparoscopic Donor Hepatectomy	22
Low Levels of Hepatocyte‐Specific Methylation in Cell‐Free DNA Are a Strong Negative Predictor for Acute T Cell–Mediated Rejection Requiring Treatment Following Liver Transplantation	22
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	21
Bariatric surgery post-liver transplantation: A Belgian nationwide study	21
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	21
Deceased Donor Liver Transplantation from a SARS‐CoV‐2–Positive Donor to a SARS‐CoV‐2–Positive Recipient	21
Liver transplantation for pediatric liver malignancies	21
Policy Corner: HCC exception update	21
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	21
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	20
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	20
When worlds collide	20
Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis	20
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs	20
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	20
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	20
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	20
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	19
Issue Information	19
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	19
Issue Information ‐ Instructions to Authors	19
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	19
Decompensated cirrhosis but low MELD – should we wait or refer for liver transplantation?	18
Effect of Acuity Circles Allocation Policy on Local Use of Donation After Circulatory Death Donor Livers	18
Long‐term quality of life of living liver donors: A Japanese nationwide survey	18
Issue Information ‐ Author Checklist	18
PRO AI: AI-augmented allocation is in our future—We should invest the necessary resources today	18
Procurement Liver Biopsies: More Scrutiny May Yield More Opportunities	18

A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action	18
The Role of Psychosocial Screening Tools in the Evaluation of Transplantation Patients With Alcohol‐Related Liver Disease	18
Reply	18
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	18
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand	18
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	17
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	17
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	17
	17
Issue Information	17
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease	16
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	16
Navigating the road to liver transplantation equity	16
The 6‐Minute Walk Test Distance Predicts Mortality in Cirrhosis: A Cohort of 694 Patients Awaiting Liver Transplantation	16
Priority for kidney after liver transplantation: A safety net for all?	16
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	16
A new tool to predict future liver allograft dysfunction?	16
Trends and Health Care Outcomes Among Living Liver Donors: Are We Ready to Expand the Donor Pool With Living Liver Donations?	16
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	15
Outcomes using steatotic liver grafts: Will machines score the final goal?	15
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	15
Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	15
The Future of Quality Improvement for Cirrhosis	15
Looking for literal improvement in liver transplant outcomes	15
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	15
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	15
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	15
Reply: ChatGPT and unknown clinical questions about liver transplantation	15
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	15
	14
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	14
Issue Information	14
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay	14
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	14
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	14
A New Hope for a New Year	14
Issue Information	14
Management of portal vein thrombosis in liver transplant candidates	14
No Salvation Without Regeneration	14
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	14
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	13
Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute‐on‐Chronic Liver Failure	13
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	13
Building a better mouse trap in liver retransplantation risk prediction: Is reSOFT the end or the beginning?	13
Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients	13
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	13
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	13
Blood Pressure Variability Early After Liver Transplantation Predicts Long‐Term Mortality	13
Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis	13
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	12
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	12
Bacterascites confers poor patient prognosis beyond MELD prediction	12
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	12
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study	12
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	12
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	12
Policy Corner: Polycystic liver disease MELD exception update	12
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	12
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	12
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	12
Reply: Methodological considerations for predicting HCC recurrence after Liver Transplantation	11
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	11
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	11
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	11
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	11
Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival	11
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	11
No transplant candidate left behind	11
Issue Information	11
Reply	11
Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?	11
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	11
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	11
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	11
Declining a Split‐Liver Offer Can Be Hazardous to Your Health	11
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma	11
Informatics-driven solutions for optimal care delivery in liver transplantation	10
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	10
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	10
Language Accessibility of Liver Transplantation Center Websites	10

Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	10
The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change	10
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	10
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution	10
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	10
Financial burden of cirrhosis is significantly reduced after liver transplantation	10
Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: What Are the Optimal Criteria?	10
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours	10
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	10
Incidence and outcomes of liver retransplantation using living donor allografts in the US	9
Reduced Discard Rates of Split Liver Grafts by Having a Combined Adult‐Pediatric LT Program	9
Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation	9
Erratum	9
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	9
Pediatric Living Donor Liver Transplantation Outcomes—Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks?	9
Issue Information	9
The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure	9
Geospatial analysis of liver donation after death by drug intoxication	9
Erratum	9
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	9
Speaking of the (Barely Legal) Elephant in the Room: Herbal or Dietary Supplement–Related Acute Liver Failure	9
Issue Information ‐ Instructions to Authors	9
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	9
Offer Acceptance Patterns for Liver Donors Aged 70 and Older	9
HATs Off to Clot Blockers: A Potential New Role for Statins After Transplantation	9
Issue Information ‐ Instructions to Authors	9
The impact of alcohol-associated liver disease on famous athletes who received Liver Transplants	9
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	8
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	8
Portopulmonary hypertension: May we agree to disagree?	8
Does hepatectomy technique matter?	8
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	8
Untangling the web of waitlist dropout in HCC	8
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	8
Second thoughts about second opinions for liver transplantation	8
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	8
Policy Corner: Cholangitis exception update	8
Measuring the Toll of Acute Illness–Derived Frailty in Decompensated Cirrhosis	8
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta‐analysis	8
Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	8
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	8
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	8
Reply	8
Reduction of hepatectomy times in Dutch organ procurement teams	8
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	8
Barriers to liver transplant referral in safety net settings: A national provider survey	8
Combination of Donor Anthropometrics With Recipient Imaging to Improve Matching in Liver Transplantation	7
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	7
Telemedicine in Hepatology: Current Applications and Future Directions	7
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	7
Erratum	7
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	7
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	7
Anonymity: What does it mean and why is it important to anonymous living liver donors?	7
Reply	7
Quantitative methods for optimizing patient outcomes in liver transplantation	7
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	7
“Winning the peace” against obesity in recipients of liver transplant	7
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	7
Maximizing outcomes by donor-recipient age matching in liver transplantation	7
The Prognostic Utility of Intraoperative Allograft Vascular Inflow Measurements in Donation After Circulatory Death Liver Transplantation	7
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Issue Information	7
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	7
Issue Information ‐ Instructions to Authors	7
Anonymous Nondirected Living Liver Donation: Has the Time Come to Formalize the Process?	7
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	7
Pregnancy Outcomes After Living Liver Donation: A Multi‐Institutional Study	7
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	7
Associations of sarcopenia with graft failure and mortality in patients undergoing living donor liver transplantation	6
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	6
A Modified liver donor risk index for pediatric liver transplant recipients	6
Reply	6
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	6
Efficiency of machine perfusion in pediatric liver transplantation	6
Low Immunoglobulin G Antibody Levels Against Severe Acute Respiratory Disease Coronavirus 2 After 2‐Dose Vaccination Among Liver Transplantation Recipients	6
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	6
Issue Information ‐ Author Checklist	6
Liver transplantation in tight junction protein‐2 deficiency associated liver disease	6
Salvaging the fatty liver for transplant: is short duration NMP enough?	6
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	6
Outcome of split‐liver transplantation from pediatric donors weighing 25 kg or less	6
Issue Information ‐ Author Checklist	6
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes	6
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	6
A scoping review of nonmedical barriers to living donor liver transplant	6
Long‐term follow‐up of living liver donors	6
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	6
Use of Livers With Fibrosis Based on Donor Hospital Biopsy: Missed Opportunities?	6
Proposing a Framework to Assess the Methodological Quality of Prognostic Models	6
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception	6
Issue Information	6
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	6
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation—a survey of the International Liver Transplantation Society (ILTS)	6
Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort	5